Related Experiment Video

Updated: Jun 3, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Few residues within an extensive binding interface drive receptor interaction and determine the specificity of

Sergey A Vishnivetskiy1, Luis E Gimenez, Derek J Francis

  • 1Department of Pharmacology, Vanderbilt University, Nashville, Tennessee 37232, USA.

The Journal of Biological Chemistry
|April 8, 2011
PubMed

Insights

Non-visual arrestins (arrestin-2 and -3) bind G protein-coupled receptors via specific surface residues, differing from visual arrestin-1

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Signaling

Background:

  • Arrestins regulate G protein-coupled receptor (GPCR) signaling, trafficking, and desensitization.
  • Visual arrestin-1 is rhodopsin-specific, while non-visual arrestins (arrestin-2, -3) interact with numerous GPCRs.
  • Understanding arrestin-GPCR interactions is crucial for drug development targeting signaling pathways.

Purpose of the Study:

  • To identify the specific residues and surfaces involved in non-visual arrestin binding to GPCRs.
  • To elucidate the distinct binding mechanisms of visual versus non-visual arrestins.
  • To determine the role of receptor phosphorylation in arrestin interactions.

Main Methods:

  • Site-directed mutagenesis (alanine substitution) of arrestin domains.
  • In vitro binding assays with arrestin-1 and rhodopsin.
  • Cell-based binding assays using arrestin-2/-3 and specific GPCRs (β2-adrenergic, M2 muscarinic, D2 dopamine).

Main Results:

  • An extensive surface on arrestin-2's concave side mediates GPCR binding.
  • Specific residues on N- and C-domains largely dictate receptor specificity.
  • Alanine substitutions blocked arrestin binding to their respective receptors, confirming critical interaction sites.
  • Non-visual arrestin binding relies more on non-phosphorylated receptor elements than direct phosphate interactions, unlike arrestin-1.

Conclusions:

  • Key residues on arrestin-2 and -3 determine GPCR binding specificity.
  • Non-visual arrestin interactions with GPCRs are distinct from arrestin-1, involving broader receptor element engagement.
  • These findings provide insights into GPCR signaling regulation and potential therapeutic targets.

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Multi-pass Transmembrane Proteins and β-barrels01:09

Multi-pass Transmembrane Proteins and β-barrels

In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...